1. Home
  2. CYTK vs GNRC Comparison

CYTK vs GNRC Comparison

Compare CYTK & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$70.05

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Logo Generac Holdlings Inc.

GNRC

Generac Holdlings Inc.

HOLD

Current Price

$233.35

Market Cap

8.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
GNRC
Founded
1997
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.9B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
GNRC
Price
$70.05
$233.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
17
Target Price
$85.59
$195.56
AVG Volume (30 Days)
1.5M
1.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
3.49
N/A
EPS
N/A
N/A
Revenue
$13,368,000.00
N/A
Revenue This Year
$341.94
$17.03
Revenue Next Year
$48.30
$10.88
P/E Ratio
N/A
$84.89
Revenue Growth
N/A
N/A
52 Week Low
$29.31
$104.90
52 Week High
$70.98
$236.00

Technical Indicators

Market Signals
Indicator
CYTK
GNRC
Relative Strength Index (RSI) 56.80 73.75
Support Level $59.23 $136.22
Resistance Level $67.75 $236.00
Average True Range (ATR) 2.38 9.98
MACD 0.33 2.44
Stochastic Oscillator 79.93 84.75

Price Performance

Historical Comparison
CYTK
GNRC

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About GNRC Generac Holdlings Inc.

Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.

Share on Social Networks: